BioCentury
ARTICLE | Company News

Mitsubishi completes NeuroDerm acquisition

October 27, 2017 6:58 PM UTC

On Oct. 18, Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) completed its acquisition of neurology company NeuroDerm Ltd. for $39 per share, or $1.1 billion (see BioCentury, July 28)....